Lack of anti-androgenic effects of equol on reproductive neuroendocrine function in the adult male rat

Hormones and Behavior

Volumn 65, Issue 1, 2014, Pages 22-31

  Loutchanwoot, Panida ^a   Srivilai, Prayook ^a   Jarry, Hubertus ^b  

^a MAHASARAKHAM UNIVERSITY   (Thailand)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Endocrine disruptor; Equol; Hypothalamic GnRH pulse generator; Prostate; Reproductive hormones; Reproductive outcomes; Sex steroid regulated gene expression

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; EQUOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLUTAMIDE; FOLLITROPIN; GONADORELIN; GONADORELIN RECEPTOR; LUTEINIZING HORMONE; MESSENGER RNA; PROLACTIN; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ANTIANDROGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; ENDOCRINE FUNCTION; EPIDIDYMIS; EPIDIDYMIS WEIGHT; ESTROGEN ACTIVITY; FEMALE; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION REGULATION; HYPOPHYSIS; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE GENITAL SYSTEM; MALE GENITAL TRACT PARAMETERS; MALE INFERTILITY; MEDIAL PREOPTIC AREA; MEDIAN EMINENCE; MEDIOBASAL HYPOTHALAMUS; NERVOUS SYSTEM FUNCTION; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROSTATE; PROSTATE WEIGHT; PROTEIN EXPRESSION; RAT; REPRODUCTION; SEMINAL VESICLE; SEMINAL VESICLE WEIGHT; TESTOSTERONE BLOOD LEVEL; UPREGULATION;

ENDOCRINE DISRUPTOR; EQUOL; HYPOTHALAMIC GNRH PULSE GENERATOR; PROSTATE; REPRODUCTIVE HORMONES; REPRODUCTIVE OUTCOMES; SEX-STEROID REGULATED GENE EXPRESSION;

ANDROGEN ANTAGONISTS; ANIMALS; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUOL; FEMALE; FLUTAMIDE; GENITALIA, MALE; GONADAL STEROID HORMONES; MALE; MONOAMINE OXIDASE INHIBITORS; NEUROSECRETORY SYSTEMS; ORGAN SIZE; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SEXUAL BEHAVIOR, ANIMAL;

EID: 84890184251     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2013.10.013     Document Type: Article

References (67)

1. Adlercreutz H., Fotsis T., Bannwart C., Wähälä K., Mäkelä T., Brunow G., Hase T. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J. Steroid Biochem. 1986, 25:791-797.
2. Adlercreutz H., Musey P.I., Fotsis T., Bannwart C., Wähälä K., Mäkelä T., Brunow G., Hase T. Identification of lignans and phytoestrogens in urine of chimpanzees. Clin. Chim. Acta 1986, 158:147-154.
3. Andrews P., Freyberger A., Hartmann E., Eiben R., Loof I., Schmidt U., Temerowski M., Becka M. Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drug flutamide. Arch. Toxicol. 2001, 75:65-73.
4. Andrews P., Freyberger A., Hartmann E., Eiben R., Loof I., Schmidt U., Temerowski M., Folkerts A., Stahl B., Kayser M. Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407). Arch. Toxicol. 2002, 75:194-202.
5. Arias P., Jarry H., Leonhardt S., Moguilevsky J.A., Wuttke W. Estradiol modulates the LH release response to N-methyl-D-aspartate in adult female rats: studies on hypothalamic luteinizing hormone-releasing hormone and neurotransmitter release. Neuroendocrinology 1993, 57:710-715.
6. Asano K., Maruyama S., Usui T., Fujimoto N. Regulation of estrogen receptor alpha and beta expression by testosterone in the rat prostate gland. Endocr. J. 2003, 50:281-287.
7. Belsham D.D., Lovejoy D.A. Gonadotropin-releasing hormone: gene evolution, expression, and regulation. Vitam. Horm. 2005, 71:59-94.
8. Blok L.J., Bartlett J.M., Bolt-De Vries J., Themmen A.P., Brinkmann A.O., Weinbauer G.F., Nieschlag E., Grootegoed J.A. Effect of testosterone deprivation on expression of the androgen receptor in rat prostate, epididymis and testis. Int. J. Androl. 1992, 15:182-198.
9. Bovee T.F., Schoonen W.G., Hamers A.R., Bento M.J., Peijnenburg A.A. Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities. Anal. Bioanal. Chem. 2008, 390:1111-1119.
10. Bowey E., Adlercreutz H., Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem. Toxicol. 2003, 41:631-636.
11. Brown N.M., Belles C.A., Lindley S.L., Zimmer-Nechemias L., Witte D.P., Kim M., Setchell K.D.R. Mammary gland differentiation by early life exposure to enantiomers of the soy isoflavone metabolite equol. Food Chem. Toxicol. 2010, 48:3042-3050.
12. Cicero T.J., Davis L.A., LaRegina M.C., Meyer E.R., Schlegel M.S. Chronic opiate exposure in the male rat adversely affects fertility. Pharmacol. Biochem. Behav. 2002, 72:157-163.
13. Gladue B.A., Clemens L.G. Flutamide inhibits testosterone-induced masculine sexual behavior in male and female rats. Endocrinology 1980, 106:1917-1922.
14. Gray G.D. Differential effects of the antiandrogen flutamide on aspects of sexual behavior in castrated, androgen-treated male rats. Psychoneuroendocrinology 1977, 2:315-320.
15. Hedlund T.E., Johannes W.U., Miller G.J. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 2003, 54:68-78.
16. Herbison A.E. Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr. Rev. 1998, 19:302-330.
17. Jarry H., Sprenger M., Wuttke W. Rates of release of GABA and catecholamines in the mediobasal hypothalamus of ovariectomized and ovariectomized estrogen-treated rats: correlation with blood prolactin levels. Neuroendocrinology 1986, 44:422-428.
18. Kang S.S., Kim S.R., Leonhardt S., Jarry H., Wuttke W., Kim K. Effect of interleukin-1beta on gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in castrated male rats. J. Neuroendocrinol. 2000, 12:421-429.
19. Kolle S.N., Melching-Kollmuss S., Krennrich G., Landsiedel R., van Ravenzwaay B. Assessment of combinations of antiandrogenic compounds vinclozolin and flutamide in a yeast based reporter assay. Regul. Toxicol. Pharmacol. 2011, 60:373-380.
20. Kumar V.L., Majumder P.K., Kumar V. Androgen deprivation causes up-regulation of androgen receptor transcript in the rat prostate. Mol. Cell. Biochem. 1997, 171:133-138.
21. Kumar V.L., Majumder P.K., Kumar V. In vivo modulation of androgen receptor by androgens. Asian J. Androl. 2002, 4:229-231.
22. Kunimatsu T., Yamada T., Miyata K., Yabushita S., Seki T., Okuno Y., Matsuo M. Evaluation for reliability and feasibility of the draft protocol for the enhanced rat 28-day subacute study (OECD Guideline 407) using androgen antagonist flutamide. Toxicology 2004, 200:77-89.
23. Labrie F. Mechanism of action and pure antiandrogenic properties of flutamide. Cancer 1993, 72:3816-3827.
24. Leonhardt S., Shahab M., Luft H., Wuttke W., Jarry H. Reduction of luteinizing hormone secretion induced by long-term feed restriction in male rats is associated with increased expression of GABA-synthesizing enzymes without alterations of GnRH gene expression. J. Neuroendocrinol. 1999, 11:613-619.
25. Lephart E.D., Setchell K.D., Handa R.J., Lund T.D. Behavioral effects of endocrine-disrupting substances: phytoestrogens. ILAR. J. 2004, 45:443-454.
26. Lieberman M.E., Maurer R.A., Gorski J. Estrogen control of prolactin synthesis in vitro. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:5946-5949.
27. Liu H., Du J., Hu C., Qi H., Wang X., Wang S., Liu Q., Li Z. Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells. J. Nutr. Biochem. 2010, 21:390-396.
28. Loutchanwoot P., Wolfgang W., Hubertus J. Effects of a 5-day treatment with vinclozolin on the hypothalamo-pituitary-gonadal axis in male rats. Toxicology 2008, 243:105-115.
29. Loutchanwoot P., Srivilai P., Hubertus J. Effects of the natural endocrine disruptor equol on the pituitary function in adult male rats. Toxicology 2013, 304:69-75.
30. Lund T.D., Munson D.J., Haldy M.E., Setchell K.D., Lephart E.D., Handa R.J. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol. Reprod. 2004, 70:1188-1195.
31. Lund T.D., Blake C., Bu L., Hamaker A.N., Lephart E.D. Equol an isoflavonoid: potential for improved prostate health, in vitro and in vivo evidence. Reprod. Biol. Endocrinol. 2011, 9:4-9.
32. Maeda K., Ohkura S., Tsukamura H. Physiology of reproduction. The Handbook of Experimental Animals: The Laboratory Rat 2000, 153-157. Academic Press, New York. G.J. Krinke (Ed.).
33. Marcondes F.K., Bianchi F.J., Tanno A.P. Determination of the estrous cycle phases of rats: some helpful considerations. Braz. J. Biol. 2002, 62:609-614.
34. Matsuura I., Saitoh T., Ashina M., Wako Y., Iwata H., Toyota N., Ishizuka Y., Namiki M., Hoshino N., Tsuchitani M. Evaluation of a two-generation reproduction toxicity study adding endpoints to detect endocrine disrupting activity using vinclozolin. J. Toxicol. Sci. 2005, 30:163-188.
35. McAbee M.D., Doncarlos L.L. Estrogen, but not androgens, regulates androgen receptor messenger ribonucleic acid expression in the developing male rat forebrain. Endocrinology 1999, 140:3674-3681.
36. McGinnis M.Y., Mirth M.C. Inhibition of cell nuclear androgen receptor binding and copulation in male rats by an antiandrogen, Sch 16423. Neuroendocrinology 1986, 43:63-68.
37. McGinnis M.Y., Williams G.W., Lumia A.R. Inhibition of male sex behavior by androgen receptor blockade in preoptic area or hypothalamus, but not amygdala or septum. Physiol. Behav. 1996, 60:783-789.
38. McGinnis M.Y., Montana R.C., Lumia A.R. Effects of hydroxyflutamide in the medial preoptic area or lateral septum on reproductive behaviors in male rats. Brain Res. Bull. 2002, 59:227-234.
39. Morton M.S., Arisaka O., Miyake N., Morgan L.D., Evans B.A. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J. Nutr. 2002, 132:3168-3171.
40. Muthyala R.S., Ju Y.H., Sheng S., Williams L.D., Doerge D.R., Katzenellenbogen B.S., Helferich W.G., Katzenellenbogen J.A. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg. Med. Chem. 2004, 12:1559-1567.
41. Neri R. Pharmacology and pharmacokinetics of flutamide. Urology 1989, 34:19-21. (discussion 46-56).
42. O'Connor J.C., Cook J.C., Slone T.W., Makovec G.T., Frame S.R., Davis L.G. An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs). Toxicol. Sci. 1998, 46:45-60.
43. O'Connor J.C., Frame S.R., Biegel L.B., Cook J.C., Davis L.G. Sensitivity of a Tier I screening battery compared to an in utero exposure for detecting the estrogen receptor agonist 17 beta-estradiol. Toxicol. Sci. 1998, 44:169-184.
44. O'Connor J.C., Frame S.R., Ladics G.S. Evaluation of a 15-day screening assay using intact male rats for identifying antiandrogens. Toxicol. Sci. 2002, 69:92-108.
45. Paisley J.C., Huddleston G.G., Carruth L.L., Petrulis A., Grober M.S., Clancy A.N. Sexual responses of the male rat medial preoptic area and medial amygdala to estrogen I: site specific suppression of estrogen receptor alpha. Horm. Behav. 2012, 62:50-57.
46. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 1973, 59:449-450.
47. A Stereotaxic Atlas of the Rat Brain 1979, Plenum Press, New York. L.J. Pellegrino, A.S. Pellegrino, A.J. Cushman (Eds.).
48. Petersen S.L., Ottem E.N., Carpenter C.D. Direct and indirect regulation of gonadotropin-releasing hormone neurons by estradiol. Biol. Reprod. 2003, 69:1771-1778.
49. Prins G.S., Birch L. Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 1997, 138:1801-1809.
50. Rachoń D., Vortherms T., Seidlová-Wuttke D., Menche A., Wuttke W. Uterotropic effects of dietary equol administration in ovariectomized Sprague-Dawley rats. Climacteric 2007, 10:416-426.
51. Rachoń D., Vortherms T., Seidlová-Wuttke D., Wuttke W. Effects of dietary equol on the pituitary of the ovariectomized rats. Horm. Metab. Res. 2007, 39:256-261.
52. Roth C., Schricker M., Lakomek M., Strege A., Heiden I., Luft H., Munzel U., Wuttke W., Jarry H. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model. J. Endocrinol. 2001, 169:361-371.
53. Roth C., Schmidberger H., Lakomek M., Witt O., Wuttke W., Jarry H. Reduction of gamma-aminobutyric acid-ergic neurotransmission as a putative mechanism of radiation induced activation of the gonadotropin releasing-hormone-pulse generator leading to precocious puberty in female rats. Neurosci. Lett. 2001, 297:45-48.
54. Roy D., Angelini N.L., Belsham D.D. Estrogen directly represses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons. Endocrinology 1999, 140:5045-5053.
55. Roy P., Salminen H., Koskimies P., Simola J., Smeds A., Saukko P., Huhtaniemi I.T. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. J. Steroid Biochem. Mol. Biol. 2004, 88:157-166.
56. Russell N.V., Ogaga-Mgbonyebi E.V., Habteab B., Dunigan A.I., Tesfay M.A., Clancy A.N. Sexual responses of the male rat medial preoptic area and medial amygdala to estrogen II: site specific effects of selective estrogenic drugs. Horm. Behav. 2012, 62:58-66.
57. Sathyamoorthy N., Wang T.T. Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur. J. Cancer 1997, 33:2384-2389.
58. Selvaraj V., Zakroczymski M.A., Naaz A., Mukai M., Ju Y.H., Doerge D.R., Katzenellenbogen J.A., Helferich W.G., Cooke P.S. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice. Biol. Reprod. 2004, 71:966-972.
59. Setchell K.D., Borriello S.P., Hulme P., Kirk D.N., Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr. 1984, 40:569-578.
60. Setchell K.D., Brown N.M., Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J. Nutr. 2002, 132:3577-3584.
61. Simard J., Luthy I., Guay J., Belanger A., Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol. Cell. Endocrinol. 1986, 44:261-270.
62. Simpkins J.W., Kalra S.P., Kalra P.S. Variable effects of testosterone on dopamine activity in several microdissected regions in the preoptic area and medial basal hypothalamus. Endocrinology 1983, 112:665-669.
63. Södersten P., Gray G., Damassa D.A., Smith E.R., Davidson J.M. Effects of a non-steroidal antiandrogen on sexual behavior and pituitary-gonadal function in the male rat. Endocrinology 1975, 97:1468-1475.
64. Sohoni P., Sumpter J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 1998, 158:327-329.
65. Tena-Sempere M., Barreiro M.L., Gonzalez L.C., Pinilla L., Aguilar E. Differential neonatal imprinting and regulation by estrogen of estrogen receptor subtypes alpha and beta and of the truncated estrogen receptor product (TERP-1) mRNA expression in the male rat pituitary. Neuroendocrinology 2001, 74:347-358.
66. Tong Y., Simard J., Labrie C., Zhao H.F., Labrie F., Pelletier G. Inhibitory effect of androgen on estrogen-induced prolactin messenger ribonucleic acid accumulation in the male rat anterior pituitary gland. Endocrinology 1989, 125:1821-1828.
67. Wood C.E., Appt S.E., Clarkson T.B., Franke A.A., Lees C.J., Doerge D.R., Cline J.M. Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys. Biol. Reprod. 2006, 75:477-486.